Oral Transmucosal Drugs
This report aims to provide a comprehensive presentation of the global market for Oral Transmucosal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Transmucosal Drugs. This report contains market size and forecasts of Oral Transmucosal Drugs in global, including the following market information:
Global Oral Transmucosal Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Oral Transmucosal Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Oral Transmucosal Drugs companies in 2022 (%)
The global Oral Transmucosal Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Transmucosal Drugs include LTS Lohmann Therapie-Systeme AG, Soligenix, ZIM Laboratories Limited, Access Pharmaceutical Inc., C.L Pharm, Cure Pharmaceutical, Aquestive Therapeutics, Inc., NAL Pharma and IntelGenx Corp., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Transmucosal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Transmucosal Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Films
Liquid Spray
Gels
Others
Global Oral Transmucosal Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, by Application, 2022 (%)
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
Global Oral Transmucosal Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Transmucosal Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oral Transmucosal Drugs revenues share in global market, 2022 (%)
Key companies Oral Transmucosal Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oral Transmucosal Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Transmucosal Drugs, market overview.
Chapter 2: Global Oral Transmucosal Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Transmucosal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Transmucosal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Transmucosal Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Transmucosal Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Transmucosal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Transmucosal Drugs Overall Market Size
2.1 Global Oral Transmucosal Drugs Market Size: 2022 VS 2030
2.2 Global Oral Transmucosal Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Oral Transmucosal Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Oral Transmucosal Drugs Players in Global Market
3.2 Top Global Oral Transmucosal Drugs Companies Ranked by Revenue
3.3 Global Oral Transmucosal Drugs Revenue by Companies
3.4 Global Oral Transmucosal Drugs Sales by Companies
3.5 Global Oral Transmucosal Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral Transmucosal Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral Transmucosal Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Transmucosal Drugs Players in Global Market
3.8.1 List of Global Tier 1 Oral Transmucosal Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Transmucosal Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Transmucosal Drugs Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Films
4.1.4 Liquid Spray
4.1.5 Gels
4.1.6 Others
4.2 By Type - Global Oral Transmucosal Drugs Revenue & Forecasts
4.2.1 By Type - Global Oral Transmucosal Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oral Transmucosal Drugs Revenue, 2024-2030
4.2.3 By Type - Global Oral Transmucosal Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Oral Transmucosal Drugs Sales & Forecasts
4.3.1 By Type - Global Oral Transmucosal Drugs Sales, 2018-2023
4.3.2 By Type - Global Oral Transmucosal Drugs Sales, 2024-2030
4.3.3 By Type - Global Oral Transmucosal Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Oral Transmucosal Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Transmucosal Drugs Market Size, 2022 & 2030
5.1.2 Cardiovascular Disorders
5.1.3 Acute Pain Managements
5.1.4 Diabetes
5.1.5 Others
5.2 By Application - Global Oral Transmucosal Drugs Revenue & Forecasts
5.2.1 By Application - Global Oral Transmucosal Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oral Transmucosal Drugs Revenue, 2024-2030
5.2.3 By Application - Global Oral Transmucosal Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Oral Transmucosal Drugs Sales & Forecasts
5.3.1 By Application - Global Oral Transmucosal Drugs Sales, 2018-2023
5.3.2 By Application - Global Oral Transmucosal Drugs Sales, 2024-2030
5.3.3 By Application - Global Oral Transmucosal Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Oral Transmucosal Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Oral Transmucosal Drugs Market Size, 2022 & 2030
6.2 By Region - Global Oral Transmucosal Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Transmucosal Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oral Transmucosal Drugs Revenue, 2024-2030
6.2.3 By Region - Global Oral Transmucosal Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Oral Transmucosal Drugs Sales & Forecasts
6.3.1 By Region - Global Oral Transmucosal Drugs Sales, 2018-2023
6.3.2 By Region - Global Oral Transmucosal Drugs Sales, 2024-2030
6.3.3 By Region - Global Oral Transmucosal Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Oral Transmucosal Drugs Revenue, 2018-2030
6.4.2 By Country - North America Oral Transmucosal Drugs Sales, 2018-2030
6.4.3 US Oral Transmucosal Drugs Market Size, 2018-2030
6.4.4 Canada Oral Transmucosal Drugs Market Size, 2018-2030
6.4.5 Mexico Oral Transmucosal Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Oral Transmucosal Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Oral Transmucosal Drugs Sales, 2018-2030
6.5.3 Germany Oral Transmucosal Drugs Market Size, 2018-2030
6.5.4 France Oral Transmucosal Drugs Market Size, 2018-2030
6.5.5 U.K. Oral Transmucosal Drugs Market Size, 2018-2030
6.5.6 Italy Oral Transmucosal Drugs Market Size, 2018-2030
6.5.7 Russia Oral Transmucosal Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Oral Transmucosal Drugs Market Size, 2018-2030
6.5.9 Benelux Oral Transmucosal Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Oral Transmucosal Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Oral Transmucosal Drugs Sales, 2018-2030
6.6.3 China Oral Transmucosal Drugs Market Size, 2018-2030
6.6.4 Japan Oral Transmucosal Drugs Market Size, 2018-2030
6.6.5 South Korea Oral Transmucosal Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Oral Transmucosal Drugs Market Size, 2018-2030
6.6.7 India Oral Transmucosal Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Oral Transmucosal Drugs Revenue, 2018-2030
6.7.2 By Country - South America Oral Transmucosal Drugs Sales, 2018-2030
6.7.3 Brazil Oral Transmucosal Drugs Market Size, 2018-2030
6.7.4 Argentina Oral Transmucosal Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Transmucosal Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Oral Transmucosal Drugs Sales, 2018-2030
6.8.3 Turkey Oral Transmucosal Drugs Market Size, 2018-2030
6.8.4 Israel Oral Transmucosal Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Oral Transmucosal Drugs Market Size, 2018-2030
6.8.6 UAE Oral Transmucosal Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 LTS Lohmann Therapie-Systeme AG
7.1.1 LTS Lohmann Therapie-Systeme AG Company Summary
7.1.2 LTS Lohmann Therapie-Systeme AG Business Overview
7.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Major Product Offerings
7.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.1.5 LTS Lohmann Therapie-Systeme AG Key News & Latest Developments
7.2 Soligenix
7.2.1 Soligenix Company Summary
7.2.2 Soligenix Business Overview
7.2.3 Soligenix Oral Transmucosal Drugs Major Product Offerings
7.2.4 Soligenix Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Soligenix Key News & Latest Developments
7.3 ZIM Laboratories Limited
7.3.1 ZIM Laboratories Limited Company Summary
7.3.2 ZIM Laboratories Limited Business Overview
7.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Major Product Offerings
7.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.3.5 ZIM Laboratories Limited Key News & Latest Developments
7.4 Access Pharmaceutical Inc.
7.4.1 Access Pharmaceutical Inc. Company Summary
7.4.2 Access Pharmaceutical Inc. Business Overview
7.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Major Product Offerings
7.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Access Pharmaceutical Inc. Key News & Latest Developments
7.5 C.L Pharm
7.5.1 C.L Pharm Company Summary
7.5.2 C.L Pharm Business Overview
7.5.3 C.L Pharm Oral Transmucosal Drugs Major Product Offerings
7.5.4 C.L Pharm Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.5.5 C.L Pharm Key News & Latest Developments
7.6 Cure Pharmaceutical
7.6.1 Cure Pharmaceutical Company Summary
7.6.2 Cure Pharmaceutical Business Overview
7.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Major Product Offerings
7.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Cure Pharmaceutical Key News & Latest Developments
7.7 Aquestive Therapeutics, Inc.
7.7.1 Aquestive Therapeutics, Inc. Company Summary
7.7.2 Aquestive Therapeutics, Inc. Business Overview
7.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Major Product Offerings
7.7.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Aquestive Therapeutics, Inc. Key News & Latest Developments
7.8 NAL Pharma
7.8.1 NAL Pharma Company Summary
7.8.2 NAL Pharma Business Overview
7.8.3 NAL Pharma Oral Transmucosal Drugs Major Product Offerings
7.8.4 NAL Pharma Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.8.5 NAL Pharma Key News & Latest Developments
7.9 IntelGenx Corp.
7.9.1 IntelGenx Corp. Company Summary
7.9.2 IntelGenx Corp. Business Overview
7.9.3 IntelGenx Corp. Oral Transmucosal Drugs Major Product Offerings
7.9.4 IntelGenx Corp. Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.9.5 IntelGenx Corp. Key News & Latest Developments
7.10 Eisai Co., Ltd.
7.10.1 Eisai Co., Ltd. Company Summary
7.10.2 Eisai Co., Ltd. Business Overview
7.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Major Product Offerings
7.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Eisai Co., Ltd. Key News & Latest Developments
7.11 Otsuka Pharmaceutical Co., Ltd.
7.11.1 Otsuka Pharmaceutical Co., Ltd. Company Summary
7.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Business Overview
7.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Major Product Offerings
7.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Otsuka Pharmaceutical Co., Ltd. Key News & Latest Developments
7.12 Teva Pharmaceutical Industries Ltd.
7.12.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Business Overview
7.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Major Product Offerings
7.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.13 GlaxoSmithKline plc
7.13.1 GlaxoSmithKline plc Company Summary
7.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Business Overview
7.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Major Product Offerings
7.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.13.5 GlaxoSmithKline plc Key News & Latest Developments
7.14 Viatris
7.14.1 Viatris Company Summary
7.14.2 Viatris Business Overview
7.14.3 Viatris Oral Transmucosal Drugs Major Product Offerings
7.14.4 Viatris Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Viatris Key News & Latest Developments
7.15 Bristol-Myers Squibb Company
7.15.1 Bristol-Myers Squibb Company Company Summary
7.15.2 Bristol-Myers Squibb Company Business Overview
7.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Major Product Offerings
7.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Bristol-Myers Squibb Company Key News & Latest Developments
8 Global Oral Transmucosal Drugs Production Capacity, Analysis
8.1 Global Oral Transmucosal Drugs Production Capacity, 2018-2030
8.2 Oral Transmucosal Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Transmucosal Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Transmucosal Drugs Supply Chain Analysis
10.1 Oral Transmucosal Drugs Industry Value Chain
10.2 Oral Transmucosal Drugs Upstream Market
10.3 Oral Transmucosal Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Transmucosal Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Oral Transmucosal Drugs in Global Market
Table 2. Top Oral Transmucosal Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oral Transmucosal Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oral Transmucosal Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Oral Transmucosal Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Oral Transmucosal Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oral Transmucosal Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Oral Transmucosal Drugs Product Type
Table 9. List of Global Tier 1 Oral Transmucosal Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Transmucosal Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Transmucosal Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Oral Transmucosal Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oral Transmucosal Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Oral Transmucosal Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Oral Transmucosal Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Oral Transmucosal Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Oral Transmucosal Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oral Transmucosal Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Oral Transmucosal Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Oral Transmucosal Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Oral Transmucosal Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Oral Transmucosal Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oral Transmucosal Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Oral Transmucosal Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Oral Transmucosal Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oral Transmucosal Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Oral Transmucosal Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Oral Transmucosal Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oral Transmucosal Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Oral Transmucosal Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oral Transmucosal Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oral Transmucosal Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Oral Transmucosal Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oral Transmucosal Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oral Transmucosal Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Oral Transmucosal Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Oral Transmucosal Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oral Transmucosal Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Oral Transmucosal Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oral Transmucosal Drugs Sales, (K Units), 2024-2030
Table 46. LTS Lohmann Therapie-Systeme AG Company Summary
Table 47. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Offerings
Table 48. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. LTS Lohmann Therapie-Systeme AG Key News & Latest Developments
Table 50. Soligenix Company Summary
Table 51. Soligenix Oral Transmucosal Drugs Product Offerings
Table 52. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Soligenix Key News & Latest Developments
Table 54. ZIM Laboratories Limited Company Summary
Table 55. ZIM Laboratories Limited Oral Transmucosal Drugs Product Offerings
Table 56. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. ZIM Laboratories Limited Key News & Latest Developments
Table 58. Access Pharmaceutical Inc. Company Summary
Table 59. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Offerings
Table 60. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Access Pharmaceutical Inc. Key News & Latest Developments
Table 62. C.L Pharm Company Summary
Table 63. C.L Pharm Oral Transmucosal Drugs Product Offerings
Table 64. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. C.L Pharm Key News & Latest Developments
Table 66. Cure Pharmaceutical Company Summary
Table 67. Cure Pharmaceutical Oral Transmucosal Drugs Product Offerings
Table 68. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Cure Pharmaceutical Key News & Latest Developments
Table 70. Aquestive Therapeutics, Inc. Company Summary
Table 71. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Offerings
Table 72. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Aquestive Therapeutics, Inc. Key News & Latest Developments
Table 74. NAL Pharma Company Summary
Table 75. NAL Pharma Oral Transmucosal Drugs Product Offerings
Table 76. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. NAL Pharma Key News & Latest Developments
Table 78. IntelGenx Corp. Company Summary
Table 79. IntelGenx Corp. Oral Transmucosal Drugs Product Offerings
Table 80. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. IntelGenx Corp. Key News & Latest Developments
Table 82. Eisai Co., Ltd. Company Summary
Table 83. Eisai Co., Ltd. Oral Transmucosal Drugs Product Offerings
Table 84. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Eisai Co., Ltd. Key News & Latest Developments
Table 86. Otsuka Pharmaceutical Co., Ltd. Company Summary
Table 87. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Offerings
Table 88. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Otsuka Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 90. Teva Pharmaceutical Industries Ltd. Company Summary
Table 91. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Offerings
Table 92. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 94. GlaxoSmithKline plc Company Summary
Table 95. GlaxoSmithKline plc Oral Transmucosal Drugs Product Offerings
Table 96. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. GlaxoSmithKline plc Key News & Latest Developments
Table 98. Viatris Company Summary
Table 99. Viatris Oral Transmucosal Drugs Product Offerings
Table 100. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Viatris Key News & Latest Developments
Table 102. Bristol-Myers Squibb Company Company Summary
Table 103. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Offerings
Table 104. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Bristol-Myers Squibb Company Key News & Latest Developments
Table 106. Oral Transmucosal Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Oral Transmucosal Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Oral Transmucosal Drugs Production by Region, 2018-2023 (K Units)
Table 109. Global Oral Transmucosal Drugs Production by Region, 2024-2030 (K Units)
Table 110. Oral Transmucosal Drugs Market Opportunities & Trends in Global Market
Table 111. Oral Transmucosal Drugs Market Drivers in Global Market
Table 112. Oral Transmucosal Drugs Market Restraints in Global Market
Table 113. Oral Transmucosal Drugs Raw Materials
Table 114. Oral Transmucosal Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Oral Transmucosal Drugs Downstream
Table 116. Oral Transmucosal Drugs Downstream Clients in Global Market
Table 117. Oral Transmucosal Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Transmucosal Drugs Segment by Type in 2022
Figure 2. Oral Transmucosal Drugs Segment by Application in 2022
Figure 3. Global Oral Transmucosal Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Transmucosal Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Oral Transmucosal Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Oral Transmucosal Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Transmucosal Drugs Revenue in 2022
Figure 9. By Type - Global Oral Transmucosal Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Oral Transmucosal Drugs Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Oral Transmucosal Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Oral Transmucosal Drugs Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Oral Transmucosal Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Oral Transmucosal Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 23. US Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 28. Germany Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 37. China Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Oral Transmucosal Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Oral Transmucosal Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Oral Transmucosal Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Oral Transmucosal Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Oral Transmucosal Drugs by Region, 2022 VS 2030
Figure 54. Oral Transmucosal Drugs Industry Value Chain
Figure 55. Marketing Channels
